Created by Caen-based startup Doctizy in October 2021, Klodios combines real-time information monitoring with collaborative tools tailored to life-science and healthcare teams. Its platform is already used by major industry players such as GlaxoSmithKline, Vertex, Sanofi and ViiV Healthcare, and a pilot collaboration has begun with the ARS de La Réunion. After two years building an initial product and two additional years refining its technical and strategic roadmap, the company is now focused on delivering a second-generation version of Klodios. The newly secured financing will fund expanded R&D, including the hiring of five additional AI engineers in 2026 and three customer-success specialists. Founders Nicolas and Clément Vivet, joined by engineer Steve Gendarme, continue to lead product development. While financial metrics such as revenue or user counts were not disclosed, the presence of blue-chip pharma clients suggests early commercial traction. The company positions its technology as a critical workflow and knowledge-management layer within the healthcare ecosystem.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2025